Clinical Trial Update: Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors [Phase 1]

View source ↗

Summary

This document provides a Phase 1 clinical trial update on using Interleukin-12 to treat various hematologic cancers and solid tumors; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Kidney Cancer
• Leukemia
• Lymphoma
• Multiple Myeloma and Plasma Cell Neoplasm
• Myelodysplastic Syndromes
• Neuroblastoma
• Ovarian Cancer

Drugs mentioned

• Interleukin-12 (interleukin-12)

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Breast Cancer, Chronic Myeloproliferative Disorders | Phase 1 | Status: COMPLETED